Kaiku Health

What Kaiku Health does

Kaiku Health is a digital health company founded in 2012 that builds a machine-learning-enabled patient monitoring platform for cancer care. The platform captures highly structured patient-reported outcome (PRO) data with reported compliance rates of 80-90%, then applies proprietary ML algorithms trained on combined patient, clinician and clinic datasets to predict the onset and continuity of symptoms — with claimed applications to earlier detection of adverse events such as peripheral sensory neuropathy (detected on average two months earlier than traditional monitoring). The company operates two primary product surfaces: 'Elekta Kaiku' for life sciences partners (co-created therapy-specific modules used as clinical-trial digital companions and post-marketing real-world data tools) and the 'Elekta ONE Patient Companion' for cancer clinics (digital health intervention and patient engagement).

Following its 2022 acquisition by Elekta AB, the publicly traded Swedish radiation oncology company, Kaiku Health operates as a wholly-owned product line within Elekta's Life Sciences division, marketed under the 'Elekta Kaiku' brand. Its business model is B2B enterprise subscription, with quote-based pricing sold directly to pharmaceutical and biotech companies for module co-creation and to cancer clinics for patient monitoring deployment. Distribution is handled through Elekta's global oncology sales organization across the USA, Switzerland, UK, Germany, Japan and Korea. Customer outcomes cited by the company include 95-99% patient recommendation rates, 86-90% reporting improved cancer care, and 57-84% reduction in patient phone calls to providers.

Revenue is not separately disclosed by Elekta; pre-acquisition the company raised approximately $6.6M cumulatively across multiple rounds, with the largest being a 2018 Series A of ~$5.4M led by Debiopharm Innovation Fund and Tesi. Following integration, growth signals include a September 2023 partnership expansion with a leading global medicines company for breast cancer digital monitoring, ASCO 2023 research presentation, and the publication of new evidence on early neuropathy detection and call-burden reduction.

Name

Kaiku Health

Legal name

Elekta Kaiku (operated by Elekta AB)

Website

https://kaikuhealth.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Kaiku Health is a digital health platform that uses machine learning on patient-reported outcomes to monitor and predict symptoms for cancer patients, serving pharmaceutical companies through co-created therapy modules and cancer clinics for patient engagement, now operating as Elekta Kaiku within Elekta AB.

Ownership category

akta.pro rank

Product category

Digital Patient Monitoring Software

NAICS

Other Computer Related Services (541519), Computer Systems Design Services (541512)

SIC

Services-Health Services (8000), Services-Prepackaged Software (7372)

akta.pro primary industry

Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD)

akta.pro secondary industries

eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB), SaMD – Monitoring, Triage & Risk Stratification Software (HLACANAE), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

Keywords

• Digital patient monitoring
• Cancer care software
• Patient-reported outcomes
• Electronic patient-reported outcomes
• Symptom tracking platform

Headquarters

HQ city

Helsinki

HQ country

Finland

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Platform Licensing to Life Sciences: B2B licensing model where pharmaceutical and life sciences companies partner to co-create therapy-specific modules and use the platform as a clinical trials digital companion for post-marketing commitments
2. Platform Deployment to Cancer Clinics: Digital health intervention platform (Elekta ONE patient companion) deployed to cancer centers for direct patient monitoring and improved treatment coordination

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

Kaiku Health (now marketed as Elekta Kaiku) provides a digital patient monitoring platform for cancer care. The platform enables electronic patient-reported outcomes (ePROs) collection and uses machine learning to predict symptom severity. It serves two customer segments: life sciences partners (pharma and biotech) through the Elekta Kaiku offering, and cancer clinics via Elekta ONE Patient Companion (formerly Kaiku Health).

Product overview

Elekta Kaiku is a unified digital patient monitoring platform for cancer care, consisting of the core Elekta Kaiku product for life sciences partners (pharmaceutical companies) and the Elekta ONE Patient Companion (formerly Kaiku Health) for cancer clinics. The platform enables co-creation of therapy-specific modules, captures patient-reported outcomes, applies machine learning for symptom prediction, and generates structured real-world data for post-marketing commitments and clinical trials support. Both offerings share the same underlying Kaiku Health technology platform.

Differentiator

Problem solved

Functional benefit

Brands

• Kaiku Health Platform: Digital patient monitoring platform for cancer care with machine learning capabilities
• Elekta ONE patient companion

Products and services

• Elekta Kaiku A digital patient monitoring platform built for life sciences companies (pharmaceutical and biotechnology firms) running oncology clinical trials and real-world evidence programs. It enables remote electronic patient-reported outcomes (ePROs) collection and applies machine learning to predict symptom severity during cancer treatment.
• Elekta ONE Patient Companion (formerly Kaiku Health) A digital symptom tracking and patient monitoring platform deployed at cancer clinics for routine clinical care. It allows patients to report symptoms between visits and supports care teams in managing side effects during cancer treatment, now part of the Elekta ONE software suite.

Quantifiable outcome

• 95-99% of patients would recommend the platform to other cancer patients
• +5 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• Leading Global Medicines Company (Breast Cancer Partnership)coreStrategic or Co-development Partner · 19 September 2023Elekta expanded partnership with a leading global medicines company to support patients living with breast cancer through the Kaiku Health digital patient monitoring platform, co-creating therapy-specific modules
• Life Sciences Partner EcosystemcoreStrategic or Co-development PartnerOpen ecosystem of life sciences partners who co-create therapy-specific modules with Elekta Kaiku to optimize treatments and maximize effectiveness for patients dealing with cancer

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Market position

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/kaikuhealth
• Facebookfacebook.com/kaikuhealth

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds4 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kaiku Health